Jun Liu

FDA investigator · also recorded as Ase A. Jun Liu

Appears on 5 documents from 2019 to 2024, most often at sites in Japan. Most often cites written procedures; deviations (21 CFR 211.100).

5
Documents on file
4.4
Observations per 483
2019
First seen
2024
Most recent

What they cite most

From 22 observations

Activity by year

2019: 1, 2021: 1, 2023: 2, 2024: 1

Where

Japan 2 · California 1 · China 1 · Pennsylvania 1

Is Jun Liu coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

5 documents, newest first
FirmOpen
483 GlaxoSmithKline LLCSep 25, 2024 · Conshohocken, Pennsylvania
483 WuXi Biologics Co. Ltd.May 9, 2023 · Wuxi, China
483 Tanvex BioPharma USA, IncJan 24, 2023 · San Diego, California
483 Daiichi Sankyo Co., Ltd.Jul 9, 2021 · Iwaki, Japan
483 Daiichi Sankyo Co., Ltd.Nov 8, 2019 · Iwaki, Japan

About this profile

What does Jun Liu inspect?

Jun Liu appears on 5 documents on file covering 4 sites, most often in Japan.

What do they cite most often?

21 CFR 211.100 (written procedures; deviations), followed by 21 CFR 211.113 and 21 CFR 211.22.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Jun Liu is dated Sep 25, 2024.

FDA Investigator Jun Liu: 483s & Inspections · FDA Intel